This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 2 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 3 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 4 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

This is default featured slide 5 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Private hospital in Kolkata launches rooftop helipad for emergency services

Kolkata's Desun Hospital successfully conducted a trial run of its newly launched rooftop helipad with an Agusta 109 SP helicopter, enhancing emergency healthcare services. Approved by the DGCA, the helipad aims to provide critical care air ambulance services for patients across West Bengal, North-East, and Eastern India, ensuring faster medical intervention.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jdTgMB9
via IFTTT

Halt illegal imports of refurbished medical gear: Drug regulator

India's drug regulator has instructed Customs to prevent the entry of refurbished medical devices, as these lack regulation under existing rules. This move addresses concerns about patient safety and supports domestic manufacturers. Imports are halted until a policy framework is established, impacting the pre-owned medical equipment market, which aids underserved regions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X6MgLZr
via IFTTT

Competition Commission of India penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal

The Competition Commission of India has imposed a Rs 40 lakh penalty on Goldman Sachs AIMPL for not notifying the regulator about a deal involving optionally convertible debentures issued by Biocon Biologics. CCI ruled the deal was strategic and required prior approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Qp1iXRJ
via IFTTT

A Healthy Dialogue: Future of health sector cooperation under the Trump administration

India faces a complex health cooperation agenda with the incoming US administration. Key focus areas include trade in pharmaceuticals, pandemic preparedness, vaccine development, digital health, and climate resilience in health systems. Ensuring continued collaboration and addressing emerging challenges requires strategic planning and negotiation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/U3PgLjh
via IFTTT

Clear labelling of industrial & medical oxygen must, PMO tells health ministry

The Prime Minister's Office has instructed the health ministry to ensure proper labelling of oxygen cylinders to differentiate medical oxygen from industrial oxygen. This action follows concerns raised by lawmaker Ajeet Madhavrao Gopchade about the importance of quality medical oxygen to prevent infections and health complications in patients, especially post-pandemic.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JNBEq85
via IFTTT

Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talent

Takeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurity. The facility aims to advance AI in drug discovery, clinical trials, and patient care. The company plans to launch its Dengue vaccine in India by 2026 and expand its focus on inflammation, oncology, and rare conditions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bRziwIJ
via IFTTT

Alembic Pharmaceuticals gets USFDA nod for generic antidepressant tablets

Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in treating major depressive disorder and schizophrenia. The approval covers strengths from 0.25 mg to 4 mg, and the market size for these tablets is estimated at USD 2 billion for the year ending September 2024.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/0xuA6hD
via IFTTT